+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Translational Medicine Faculty Starter Grant

Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

The PhRMA Foundation Faculty Starter Grant in Translational Medicine offers financial support to individuals beginning independent research careers at the faculty level at an accredited U.S. university.

Letter of Intent DeadlineMay 27, 2026 @
12:00 p.m. (noon) Eastern Time
11:00 a.m. Central Time
10:00 a.m. Mountain Time
9:00 a.m. Pacific Time

Program Vision

Translational medicine aims to bring scientific research and technological advancements from the laboratory to the clinic, where they can enhance the prevention, diagnosis, and treatment of disease. This includes adapting hypothesis-driven basic research discoveries in cells, tissues, and animals for application in humans and then taking the knowledge of what did and didn’t work in the clinic back to the bench. The PhRMA Foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, therapeutic, and computational approaches and technologies to improve patient care.

Scope of Research

Research areas could include, but are not limited to:

Development of innovative diagnostic or therapeutic approaches in human-relevant model systems for improving treatment in disease areas with unmet clinical need
Development and application of precision medicine approaches (molecular epidemiology, genetics, epigenetics, multi-omics) to stratify patients, elucidate inter-individual variability in humans, and inform therapeutic decision-making
Development and validation of novel surrogate, intermediate, or digital clinical endpoints for currently used treatments or those in development for humans
Development and validation of human-relevant experimental and computational approaches that reduce reliance on animal testing
Hypothesis-driven, innovative modeling and simulation approaches (including computational and AI-enabled methods) that include biological validation to support clinical decision-making
Translational pharmacokinetics (PK) and pharmacodynamics (PD) that bridge animal and in vitro data to humans, including PK/PD and PK-biomarker modeling to predict clinical outcomes
Hypothesis-based target, biomarker, and model validation using human data or human-derived systems

Requirements

All proposals must clearly state a therapeutically relevant hypothesis. Applicants are expected to work with clinical collaborators to identify unmet clinical needs. Proposals that aim to corroborate results from model systems must include methods to validate findings in humans or human-relevant systems. While preferences are given to studies where applicants collect human samples, reasoning must be clearly stated in the research plan if using only human data from pre-existing biobanks.

Computational approaches must include a clear and feasible plan for translational validation to human-relevant systems. Proposals that involve AI approaches (i.e., data-driven ML/DL) must clearly document and reference the methodology, explain the data curation process (sources, quality, quantity), and detail the validation process.

Nonresponsive

Projects focused solely on characterization, mapping, profiling, or descriptive biology without an explicit scientific hypothesis on a therapeutic decision or target are not responsive. Proposals with only animal models and no human components will not be considered.

Human components could include but are not limited to:

Humanized models with justification
Clinical biospecimens
Real-world clinical datasets
Clinical studies

Note: Please ensure you are applying to the correct PhRMA Foundation program. If your project does not align with the goals of the Translational Medicine Program, as outlined above, please review the Foundation’s Drug Discovery and Drug Delivery programs to see whether your project fits into one of those programs. Contact the Foundation (info@phrmafoundation.org) with your project description if you need further clarification.

AI Based Application Success Predictor

Based on funding priorities and awarded projects:

🥇 1. Strong Alignment with Pharmaceutical Sciences (Top Predictor)

Must focus on:
- Drug discovery
- Clinical pharmacology
- Translational research

✔ Clear link to drug development is essential

🥈 2. Early Career Investigator Focus

Most grants target:
- Students
- Postdocs
- Junior faculty

✔ Predictor:

Strong mentorship plan

🥉 3. Scientific Merit & Rigor

Requires:
- Solid methodology
- Clear hypothesis

✔ Strong experimental design is critical

4. Translational Relevance

Preference for:
- Research bridging:
  - Lab → clinic

✔ High success:

PK/PD studies
Clinical pharmacology

5. Feasibility & Training Value

Must demonstrate:
- Achievable project
- Skill development for applicant

6. Innovation in Drug Development

Competitive proposals include:
- Novel targets
- New methodologies

7. Strong Mentorship & Institutional Support

Critical factor:
- Experienced mentor
- Supportive environment

8. Health Outcomes & Real-World Impact

Especially important for:
- HEOR proposals

✔ Focus on:

Value-based care
Patient outcomes

🧪 Common Funded Research Areas

Drug discovery and development
Clinical pharmacology
Pharmacokinetics/pharmacodynamics
Health economics and outcomes research
Translational medicine

⚠️ Common Reasons for Rejection

Weak alignment with drug development
Poor mentorship plan
Lack of feasibility
Limited training value
Weak study design

🧠 Bottom Line (Key Predictors Ranked)

Alignment with pharmaceutical sciences
Early-career focus + mentorship
Strong scientific rigor
Translational relevance
Feasible, well-designed project
Training and career development value

✔️ In short:
PhRMA Foundation funding favors early-career researchers working on drug development-related science, with strong emphasis on mentorship, training, and translational impact.

Specialties

Pharmaceuticals

Eligibility Requirements

Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty at a PhD-granting accredited U.S. university by the time of LOI submission.
Applicants are ineligible if their faculty status began before January 1, 2025.
Applicants are ineligible if their last terminal degree was conferred before January 1, 2017.
Applicants must be eligible to apply for independent external research funding by their university.
Applicants should not have other substantial sources of research funding, excluding intramural funding or startup funding from their university. Preference will be given to applicants with startup funding less than $750,000.
Applicants are ineligible if they are the principal investigator (PI) of an R or K series award from the National Institutes of Health (NIH), a CAREER award from the National Science Foundation, or other substantial financial award from any grant-making institution. Generally, funding over $250,000 a year is considered substantial, unless you are the PI of a grant where funds go to training others. If this is the case, explain in your extended letter.
Applicants are ineligible if they do not have at least three first author publications.
Only one applicant per lab may apply in the Translational Medicine Program. Labs must select either a predoc, a postdoc, or a faculty member.

Sponsor Details

Sponsor Institute/Organizations: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

Sponsor Type: Corporate/Non-Profit

Address: 670 Maine Avenue SW, Suite 1000 Washington DC, 20024-3556 (202) 572-7756

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity